Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

An animal model of a newly emerging human ehrlichiosis.

Saito TB, Thirumalapura NR, Shelite TR, Rockx-Brouwer D, Popov VL, Walker DH.

J Infect Dis. 2015 Feb 1;211(3):452-61. doi: 10.1093/infdis/jiu372. Epub 2014 Jul 2. Erratum in: J Infect Dis. 2015 Jun 15;211(12):2025.

2.

A Tick Vector Transmission Model of Monocytotropic Ehrlichiosis.

Saito TB, Walker DH.

J Infect Dis. 2015 Sep 15;212(6):968-77. doi: 10.1093/infdis/jiv134. Epub 2015 Mar 3.

3.

Recombinant Ehrlichia P29 protein induces a protective immune response in a mouse model of ehrlichiosis.

Thirumalapura NR, Crocquet-Valdes PA, Saito TB, Thomas S, McBride JW, Walker DH.

Vaccine. 2013 Dec 5;31(50):5960-7. doi: 10.1016/j.vaccine.2013.10.036. Epub 2013 Oct 19.

4.

Experimental evaluation of Peromyscus leucopus as a reservoir host of the Ehrlichia muris-like agent.

Lynn GE, Oliver JD, Cornax I, O'Sullivan MG, Munderloh UG.

Parasit Vectors. 2017 Jan 28;10(1):48. doi: 10.1186/s13071-017-1980-4.

5.

Co-Feeding Transmission of the Ehrlichia muris-Like Agent to Mice (Mus musculus).

Karpathy SE, Allerdice ME, Sheth M, Dasch GA, Levin ML.

Vector Borne Zoonotic Dis. 2016 Mar;16(3):145-50. doi: 10.1089/vbz.2015.1878. Epub 2016 Jan 29.

7.

Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Walker DH, Ismail N, Olano JP, McBride JW, Yu XJ, Feng HM.

Trans Am Clin Climatol Assoc. 2004;115:375-82; discussion 382-4. Review.

8.
9.

An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection.

Stevenson HL, Jordan JM, Peerwani Z, Wang HQ, Walker DH, Ismail N.

Infect Immun. 2006 Aug;74(8):4856-64.

10.

Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.

Thirumalapura NR, Crossley EC, Walker DH, Ismail N.

Infect Immun. 2009 Dec;77(12):5682-9. doi: 10.1128/IAI.00720-09. Epub 2009 Oct 5.

11.

A real-time PCR assay for detection of the Ehrlichia muris-like agent, a newly recognized pathogen of humans in the upper Midwestern United States.

Allerdice MEJ, Pritt BS, Sloan LM, Paddock CD, Karpathy SE.

Ticks Tick Borne Dis. 2016 Feb;7(1):146-149. doi: 10.1016/j.ttbdis.2015.10.004. Epub 2015 Oct 22.

12.
13.
14.

Animal model of fatal human monocytotropic ehrlichiosis.

Sotomayor EA, Popov VL, Feng HM, Walker DH, Olano JP.

Am J Pathol. 2001 Feb;158(2):757-69.

16.

Tick-borne ehrlichiosis infection in human beings.

Ganguly S, Mukhopadhayay SK.

J Vector Borne Dis. 2008 Dec;45(4):273-80. Review.

17.
18.

Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis.

IJdo JW, Wu C, Telford SR 3rd, Fikrig E.

Infect Immun. 2002 Sep;70(9):5295-8.

19.

Experimental infection of dairy calves with Ehrlichia chaffeensis.

delos Santos JR, Boughan K, Bremer WG, Rizzo B, Schaefer JJ, Rikihisa Y, Needham GR, Capitini LA, Anderson DE, Oglesbee M, Ewing SA, Stich RW.

J Med Microbiol. 2007 Dec;56(Pt 12):1660-8.

20.

Proposal to reclassify Ehrlichia muris as Ehrlichia muris subsp. muris subsp. nov. and description of Ehrlichia muris subsp. eauclairensis subsp. nov., a newly recognized tick-borne pathogen of humans.

Pritt BS, Allerdice MEJ, Sloan LM, Paddock CD, Munderloh UG, Rikihisa Y, Tajima T, Paskewitz SM, Neitzel DF, Hoang Johnson DK, Schiffman E, Davis JP, Goldsmith CS, Nelson CM, Karpathy SE.

Int J Syst Evol Microbiol. 2017 Jul;67(7):2121-2126. doi: 10.1099/ijsem.0.001896. Epub 2017 Jul 12.

Supplemental Content

Support Center